Life Sciences Companies Worldwide Go Digital to Meet Pandemic Challenges
ISG Provider Lens™ report highlights a significant shift in the life sciences sector towards digital technologies due to the COVID-19 pandemic. The 2021 report emphasizes the adoption of automation, artificial intelligence, and cloud services to enhance clinical development and patient engagement. Key providers such as Capgemini and Cognizant are noted as leaders in the field. The demand for digital clinical trials and supply chain solutions has surged, along with the increasing need for remote monitoring and business intelligence to improve patient outcomes.
- Increased demand for digital transformation services in life sciences.
- Leading providers like Capgemini and Cognizant recognized for their capabilities.
- Growth in the adoption of automation and AI technologies.
- None.
ISG Provider Lens™ report sees companies focused on improving supply chain processes and embracing automation
The 2021 ISG Provider Lens™ Life Sciences Digital Services Global Report finds all segments of the industry adapting their strategies and processes to respond to the pandemic. A big part of those changes is the adoption of new technologies including artificial intelligence and automation and business intelligence to monitor the supply chain.
“Challenges such as the need to rapidly implement telemedicine and enable direct-to-patient data collection while maintaining cybersecurity have increased demands for digital solutions in the life sciences industry,” said
Top technology service providers have been able to rapidly implement digital solutions for the industry based on the strategies and investments they set in motion prior the pandemic, the report says. Some providers leveraged solutions they were already using in other sectors to support the sudden shift to digital services in the life sciences industry.
Other providers focused solely on life sciences, such as contract research organizations (CROs), were already deeply invested in digital roadmaps based on their own understanding of where the market would need to go to achieve necessary efficiencies and economies of scale, the report says. The pandemic provided added impetus for life sciences companies to begin working with these service providers.
The increased reliance on digital technologies is associated with other trends across the industry, the report says. These include higher demand for cloud services to support the needs of a growing remote workforce and the need for additional computing power. Changing business needs have also elevated demand for software-as-a-service solutions that can turn large volumes of data into business intelligence. Many life sciences companies are also interested in using advanced analytics, artificial intelligence and automation to enhance operations in MedTech, pharmacovigilance and regulatory affairs.
In the area of clinical development, the report sees demand growing for digital clinical trials and for advanced analytics. These require both CROs and technology providers to offer standardized, but customizable, solutions that companies can rapidly implement.
Meanwhile, many life sciences companies also want to improve patient experience and outcomes, the report says. Digital services providers have been focusing on remote monitoring, using devices, wearables, sensors and smart pills to ensure compliance and patient retention.
In addition, well-documented supply chain and logistics challenges in other industries have also affected life sciences companies, the report says. These problems have raised the demand for supply chain business intelligence services. Leading service providers are using sensors to monitor real-time shipping data, combined with expertise in advanced analytics.
The 2021 ISG Provider Lens™ Life Sciences Digital Services Global Report evaluates the capabilities of 27 providers across three quadrants: Clinical Development Digital Transformation Services, Patient Engagement Digital Transformation Services and Manufacturing Supply Chain Digital Transformation Services.
The report names Capgemini, Cognizant, HCL, TCS and Wipro as Leaders in all three quadrants. Accenture,
In addition, Hexaware, LTI and Verizon were named Rising Stars—companies with “promising portfolios” and “high future potential” by ISG’s definition—in one quadrant.
A customized version of the report is available from Hexaware.
The 2021 ISG Provider Lens™ Life Sciences Digital Services Global Report is available to subscribers or for one-time purchase on this webpage.
About ISG Provider Lens™ Research
The ISG Provider Lens™ Quadrant research series is the only service provider evaluation of its kind to combine empirical, data-driven research and market analysis with the real-world experience and observations of ISG's global advisory team. Enterprises will find a wealth of detailed data and market analysis to help guide their selection of appropriate sourcing partners, while ISG advisors use the reports to validate their own market knowledge and make recommendations to ISG's enterprise clients. The research currently covers providers offering their services globally, across
A companion research series, the ISG Provider Lens Archetype reports, offer a first-of-its-kind evaluation of providers from the perspective of specific buyer types.
About ISG
ISG (
View source version on businesswire.com: https://www.businesswire.com/news/home/20220126005245/en/
+1 203 517 3119
will.thoretz@isg-one.com
+1 617 755 2985
isg@matternow.com
Source:
FAQ
What does the 2021 ISG Provider Lens report reveal about life sciences companies' strategies?
Which companies are identified as leaders in the 2021 ISG Provider Lens report for life sciences digital services?
How are life sciences companies improving patient experiences according to the ISG report?
What role does automation play in life sciences as per the ISG Provider Lens report?